Does Horizon Blue Cross Blue Shield of New Jersey Cover Mounjaro?
The verdict
Conditional on most plans
Horizon Blue Cross Blue Shield of New Jersey covers Mounjaro for type 2 diabetes with prior authorization across commercial, ACA, and Medicare Part D lines. Mounjaro is not covered for weight loss. Important NJ nuance: New Jersey Medicaid covers some weight-loss GLP-1s — but that applies to the on-label products (Wegovy, Zepbound), not Mounjaro, which remains diabetes-only. The weight-loss tirzepatide is Zepbound.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Horizon Blue Cross Blue Shield of New Jersey using your member ID.
Key facts
New Jersey Medicaid covers some weight-loss GLP-1s (Wegovy, Zepbound) with PA — but Mounjaro is excluded from that weight-loss benefit because it is FDA-approved for type 2 diabetes only.
NJ Division of Medical Assistance and Health Services, Medicaid PDL
Mounjaro (tirzepatide) and Zepbound (tirzepatide) share the same active ingredient but carry distinct FDA approvals: Mounjaro for type 2 diabetes; Zepbound for chronic weight management and OSA.
FDA, Mounjaro and Zepbound Prescribing Information, 2023–2024
The 2026 Medicare Part D out-of-pocket cap is $2,100. Most continuous Mounjaro users for diabetes reach the cap within 2-3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2026
Medicare vs. commercial coverage
Whether Horizon Blue Cross Blue Shield of New Jersey covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Horizon BCBS of NJ Medicare Part D and Medicare Advantage plans cover Mounjaro for type 2 diabetes only — not weight loss — at a specialty or non-preferred tier with prior authorization. The 2026 Part D out-of-pocket cap is $2,100; most continuous users reach it within 2-3 months and pay $0 thereafter. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. The Lilly savings card is not usable by Medicare beneficiaries.
Commercial / Employer
Group & marketplace plans
Horizon BCBS of NJ Commercial/Employer plans cover Mounjaro for type 2 diabetes with prior authorization. Off-label weight-loss use is not covered. ACA/Individual: covered for T2D with PA; weight-loss GLP-1s are commonly excluded on commercial ACA plans. Medicaid (NJ FamilyCare): NJ Medicaid covers some weight-loss GLP-1s with PA — but only for the on-label weight-loss products (Wegovy, Zepbound). Mounjaro is covered for T2D with PA but is not a weight-loss-covered product under NJ Medicaid. The Lilly savings card ($25/month with coverage; $499/month without) applies to commercially insured patients only, not government programs.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month; up to 13 fills; expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial with coverage: Lilly savings card as low as $25/month. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; most continuous users reach the cap in 2-3 months. MFN price $245/month mid-2026 for Medicare. NJ Medicaid: nominal cost-share for T2D coverage.
Typical monthly copay once prior authorization is approved.
All figures are estimates; actual cost-share varies by plan tier and pharmacy. Verify on your Horizon BCBSNJ plan formulary or member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Mounjaro on the Horizon BCBS of NJ formulary
Visit horizonblue.com and use the drug formulary search for your specific commercial, Medicare, or Medicaid plan. Search for 'Mounjaro' or 'tirzepatide' and confirm it is listed for diabetes (ICD-10 E11.x). Note the tier, prior authorization requirement, and any quantity limits.
- 2
Work with your prescriber on the PA submission
Your prescriber must document your confirmed T2D diagnosis, A1c of 6.5% or higher, and prior use of metformin or a documented contraindication. Submit the prior authorization through your prescriber's office; allow up to 72 hours for standard review.
- 3
Call Horizon BCBS of NJ member services to clarify NJ Medicaid and weight-loss rules
Call the number on the back of your Horizon card. Ask: Is Mounjaro covered for type 2 diabetes on my plan? Is Mounjaro covered for weight loss? (Answer: No.) If you are on NJ Medicaid, note that NJ does cover some weight-loss GLP-1s — but that applies to Wegovy and Zepbound, not Mounjaro.
Options if Horizon Blue Cross Blue Shield of New Jersey won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Commonly covered on Horizon BCBS of NJ formularies with prior authorization.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative frequently on preferred tiers with lower list price than Mounjaro.
Jardiance (empagliflozin)
SGLT2 inhibitor approved for T2D with cardiovascular benefits. Often covered at preferred tiers on Horizon BCBS of NJ commercial and Medicaid plans.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management — not diabetes. Under NJ Medicaid, Zepbound (not Mounjaro) is the weight-loss tirzepatide with potential Medicaid coverage. Coverage requires a separate weight-loss indication approval.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Horizon does not cover Mounjaro for weight loss under any line of business. Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss requests are denied. For weight loss, the same active ingredient (tirzepatide) is sold as Zepbound. On NJ Medicaid, Zepbound (not Mounjaro) is the product covered under the weight-loss GLP-1 benefit.
Yes, for type 2 diabetes — with prior authorization and nominal Medicaid cost-share. New Jersey Medicaid is notable for covering some weight-loss GLP-1s, but that applies only to the on-label weight-loss products (Wegovy, Zepbound). Mounjaro's NJ Medicaid coverage is for type 2 diabetes only. Verify on your specific NJ FamilyCare plan or call member services.
Mounjaro (tirzepatide) and Zepbound (tirzepatide) are the same molecule but carry different FDA approvals. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. Under Horizon BCBS of NJ, Mounjaro is covered for diabetes with PA. Under NJ Medicaid, Zepbound (not Mounjaro) may qualify for the weight-loss GLP-1 benefit. They are not interchangeable for insurance purposes.
Horizon requires a confirmed type 2 diabetes diagnosis (ICD-10 E11.x), A1c of 6.5% or greater, and documented trial or failure of metformin (and often one additional agent). Patient must be 18 or older. Quantity limit is typically 4 pens per 28 days. Your prescriber submits the PA. Verify specific criteria on the Horizon BCBSNJ formulary or PA policy.
Only if you have a Horizon commercial (employer-sponsored or individual) plan, not Medicare or Medicaid. Commercially insured members with Mounjaro coverage may pay as little as $25/month; without coverage, $499/month (max $647/month; up to 13 fills; expires 12/31/2026). The card is not available to Horizon Medicare Part D, Medicare Advantage, or NJ Medicaid beneficiaries.
Related Articles
Does Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Horizon BCBS of New Jersey Cover Ozempic? 2026 | Curex
Horizon BCBS NJ covers Ozempic for T2D with PA — not weight loss. NJ FamilyCare Medicaid covers T2D. NovoCare $25/mo for commercial T2D. Verify on Horizon.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreDoes Horizon BCBS New Jersey Cover Wegovy? 2026 | Curex
Horizon BCBS NJ may cover Wegovy with prior authorization (BMI 30+ or 27+ with comorbidity), but coverage is plan-dependent. Verify on Horizon's formulary.
Read moreDoes Blue Cross Blue Shield of Texas Cover Mounjaro? 2026 | Curex
BCBS of Texas covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The weight-loss tirzepatide is Zepbound, covered separately.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Horizon covers Mounjaro for diabetes only — even where NJ Medicaid covers weight-loss GLP-1s, that applies to Zepbound and Wegovy, not Mounjaro. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Horizon Blue Cross Blue Shield of New Jersey before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.